Ghorbanihaghjo, Amir <br/><br/>
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.  [electronic resource] 

 -  Clinical and experimental nephrology  Feb 2008 
 - 65-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1342-1751 
<br/><br/><label>Standard No.: </label>10.1007/s10157-007-0001-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>8-Hydroxy-2'-Deoxyguanosine<br/>Adult<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Ataxia Telangiectasia Mutated Proteins<br/>Biomarkers--blood<br/>Cell Cycle Proteins--genetics<br/>DNA Damage--drug effects<br/>Deoxyguanosine--analogs & derivatives<br/>Enalapril--therapeutic use<br/>Female<br/>Humans<br/>Kidney Transplantation--methods<br/>Lipid Peroxidation<br/>Losartan--therapeutic use<br/>Male<br/>Malondialdehyde--blood<br/>Peptidyl-Dipeptidase A--genetics<br/>Polymorphism, Genetic<br/>Protein Serine-Threonine Kinases--genetics<br/>Renin-Angiotensin System--genetics